Apol1 Kidney Disease Akd clinical trials

Explore recruiting apol1 kidney disease akd clinical trials.

Recruiting apol1 kidney disease akd studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Apol1 Kidney Disease Akd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Apol1 Kidney Disease Akd trials by city

Apol1 Kidney Disease Akd in Toronto Apol1 Kidney Disease Akd in Vancouver Apol1 Kidney Disease Akd in Montreal Apol1 Kidney Disease Akd in Calgary Apol1 Kidney Disease Akd in Edmonton Apol1 Kidney Disease Akd in Ottawa Apol1 Kidney Disease Akd in Winnipeg Apol1 Kidney Disease Akd in Quebec City Apol1 Kidney Disease Akd in Hamilton Apol1 Kidney Disease Akd in Kitchener Apol1 Kidney Disease Akd in London Apol1 Kidney Disease Akd in Halifax Apol1 Kidney Disease Akd in New York Apol1 Kidney Disease Akd in Los Angeles Apol1 Kidney Disease Akd in Chicago Apol1 Kidney Disease Akd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease